Man buys HIV drug supply and the price goes up through the roof

[nickiknack]

PharmaDouche is the biggest Drama Queen ever

[niam2023]

Of course he wouldn't actually punch a wall. If he even works out, he probably has a private little gym with ten pound weights all over the place, so he doesn't need to associate with, gasp, the common man.

[ironbite]

Pharma Douche is mad.  How mad?  This mad.

As is well-known by now, one of the side effects of Daraprim, a medication needed by many AIDS and cancer patients, is uncontrollable rage — not because of any chemical properties of the drug itself, but because Martin Shkreli’s Turing Pharmaceuticals raised the price by more than 5,000 percent immediately after purchasing the rights to the medication. Until Shkreli’s greed caused the price to very quickly inflate, the lifesaving pill, which has been on the market longer than Shkreli has been alive, sold for just $13.50 per pill.

Shkreli provided numerous excuses for the price increase, the unfairness of which made headlines for weeks after the rather transparent attempt to effectively hold patients at gunpoint and rob them blind. While “Pharma Bro” ultimately promised to lower prices to an undefined amount at an unspecified point in time — something that has still not happened — another company has taken it upon themselves to completely embarrass the former hedge funder, who described the price increase as necessary.

San Diego-based Imprimis Pharmaceuticals, Inc announced on Thursday that it will be providing an alternative to Daraprim that costs a fraction of the pill’s pre-Shkreli price. The drug will be sold at as low as $99 for a 100-pill supply. Yes, that’s just about a dollar per pill.

And the system works.

Ironbite-go punch a wall for real Pharma Bro.

[guizonde]

Pharma Douche is mad.  How mad?  This mad.

As is well-known by now, one of the side effects of Daraprim, a medication needed by many AIDS and cancer patients, is uncontrollable rage — not because of any chemical properties of the drug itself, but because Martin Shkreli’s Turing Pharmaceuticals raised the price by more than 5,000 percent immediately after purchasing the rights to the medication. Until Shkreli’s greed caused the price to very quickly inflate, the lifesaving pill, which has been on the market longer than Shkreli has been alive, sold for just $13.50 per pill.

Shkreli provided numerous excuses for the price increase, the unfairness of which made headlines for weeks after the rather transparent attempt to effectively hold patients at gunpoint and rob them blind. While “Pharma Bro” ultimately promised to lower prices to an undefined amount at an unspecified point in time — something that has still not happened — another company has taken it upon themselves to completely embarrass the former hedge funder, who described the price increase as necessary.

San Diego-based Imprimis Pharmaceuticals, Inc announced on Thursday that it will be providing an alternative to Daraprim that costs a fraction of the pill’s pre-Shkreli price. The drug will be sold at as low as $99 for a 100-pill supply. Yes, that’s just about a dollar per pill.

And the system works.

Ironbite-go punch a wall for real Pharma Bro.

good. it's a shame it took a scumbag to ultimately release a pill to lower the price of the original, but hey. props where they're due, that's a great "fuck you" to pharma douche, great news to sufferers, and a step in the right direction. now if only there were failsafes to prevent the original douchebaggery from happening in the first place, patients would really rejoice.

[I am lizard]

The issue is now we need to fix the system so this can't happen again.

[nickiknack]

Nothing is more refreshing than PharmaDouche tears.

[Barbarella]

Pharma Douche is mad.  How mad?  This mad.

As is well-known by now, one of the side effects of Daraprim, a medication needed by many AIDS and cancer patients, is uncontrollable rage — not because of any chemical properties of the drug itself, but because Martin Shkreli’s Turing Pharmaceuticals raised the price by more than 5,000 percent immediately after purchasing the rights to the medication. Until Shkreli’s greed caused the price to very quickly inflate, the lifesaving pill, which has been on the market longer than Shkreli has been alive, sold for just $13.50 per pill.

Shkreli provided numerous excuses for the price increase, the unfairness of which made headlines for weeks after the rather transparent attempt to effectively hold patients at gunpoint and rob them blind. While “Pharma Bro” ultimately promised to lower prices to an undefined amount at an unspecified point in time — something that has still not happened — another company has taken it upon themselves to completely embarrass the former hedge funder, who described the price increase as necessary.

San Diego-based Imprimis Pharmaceuticals, Inc announced on Thursday that it will be providing an alternative to Daraprim that costs a fraction of the pill’s pre-Shkreli price. The drug will be sold at as low as $99 for a 100-pill supply. Yes, that’s just about a dollar per pill.

And the system works.

Ironbite-go punch a wall for real Pharma Bro.

YEAH, BABY!
IN....YO....FACE....PHARMA....DOUCHE!!!!

[Damen]

Pharma Douche is mad.  How mad?  This mad.

As is well-known by now, one of the side effects of Daraprim, a medication needed by many AIDS and cancer patients, is uncontrollable rage — not because of any chemical properties of the drug itself, but because Martin Shkreli’s Turing Pharmaceuticals raised the price by more than 5,000 percent immediately after purchasing the rights to the medication. Until Shkreli’s greed caused the price to very quickly inflate, the lifesaving pill, which has been on the market longer than Shkreli has been alive, sold for just $13.50 per pill.

Shkreli provided numerous excuses for the price increase, the unfairness of which made headlines for weeks after the rather transparent attempt to effectively hold patients at gunpoint and rob them blind. While “Pharma Bro” ultimately promised to lower prices to an undefined amount at an unspecified point in time — something that has still not happened — another company has taken it upon themselves to completely embarrass the former hedge funder, who described the price increase as necessary.

San Diego-based Imprimis Pharmaceuticals, Inc announced on Thursday that it will be providing an alternative to Daraprim that costs a fraction of the pill’s pre-Shkreli price. The drug will be sold at as low as $99 for a 100-pill supply. Yes, that’s just about a dollar per pill.

And the system works.

Ironbite-go punch a wall for real Pharma Bro.

[Cerim Treascair]

As a note, Imprimis Pharmaceuticals also has said openly that they're planning on similarly-priced generics of nearly every other medically-needed pill the FDA has approved within the next three years.  That's 7,500 medications or so.

[guizonde]

As a note, Imprimis Pharmaceuticals also has said openly that they're planning on similarly-priced generics of nearly every other medically-needed pill the FDA has approved within the next three years.  That's 7,500 medications or so.

that's... really smart. they're sweeping the competition under the rug while simultaneously striving for the greater good. i dunno who their pr department is, but they're about to get a raise (and boners. but mostly a raise and boners)

[nickiknack]

I've seen some LOLibertarians calling this a triumph of the free market, and then they go onto bs and say that government have never lowered the price of drugs, ignoring the laws in place that allow for negotiation that done is other countries due to having socialized healthcare. Aren't LOLibertartians cute, and clueless??

[Barbarella]

As a note, Imprimis Pharmaceuticals also has said openly that they're planning on similarly-priced generics of nearly every other medically-needed pill the FDA has approved within the next three years.  That's 7,500 medications or so.

I'm going to give the CEO of Imprimis Pharmaceuticals a HUGE HUG!

Frankly, EVERY med should have a generic version. I take Fluoxetine, the generic version of Prozac. Only a couple of bucks, baby!

My Mom, however, has some important meds that she NEEDS and there's no generic. She has to pay over 35-40 dollars for a refill. I hope one of the generic meds Imprimis introduces is a generic form of THAT. My Mom would be so happy!

[guizonde]

As a note, Imprimis Pharmaceuticals also has said openly that they're planning on similarly-priced generics of nearly every other medically-needed pill the FDA has approved within the next three years.  That's 7,500 medications or so.

I'm going to give the CEO of Imprimis Pharmaceuticals a HUGE HUG!

Frankly, EVERY med should have a generic version. I take Fluoxetine, the generic version of Prozac. Only a couple of bucks, baby!

My Mom, however, has some important meds that she NEEDS and there's no generic. She has to pay over 35-40 dollars for a refill. I hope one of the generic meds Imprimis introduces is a generic form of THAT. My Mom would be so happy!

there's been a huge pr campaign in france for the past ten years or so to try and get people to grab the generics rather than the brands to try and stem the social security deficit. last week when i went to the pharmacy, the pharmacist actually apologized for giving me risperdal (instead of the generic risperidone). still cost me nothing, because they said that their missing stock was their fault, so they covered the cost themselves rather than make me pay for their error. good guys, those pharmacists.

[dpareja]

One thing about generics is that (at least up here) quality control can be lower than on the brand-name drugs. There's one drug I take that does have generics, and I do fine with them, but I've at least read reports of people who need the brand-name version.

[Sigmaleph]

Frankly, EVERY med should have a generic version. I take Fluoxetine, the generic version of Prozac. Only a couple of bucks, baby!

You need patents to expire to have generics. And getting rid of patents has the problem that new drug research is expensive as fuck and companies won't do it if they can't get some economic benefit out of being the first to discover a drug.